Trade Summary
3 days ago, Henderson Jane, serving as CFO at Apogee Therapeutics, Inc. (APGE), sold 2,000 shares at $70.22 per share, for a total transaction value of $140,431.00. Following this transaction, Henderson Jane now holds 181,371 shares of APGE.
This sale represents a 1.00% decrease in Henderson Jane's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.
Apogee Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
